CRISPR/Cas9 advances engineering of microbial cell factories

被引:148
|
作者
Jakociunas, Tadas [1 ]
Jensen, Michael K. [1 ]
Keasling, Jay D. [1 ,2 ,3 ,4 ,5 ]
机构
[1] Tech Univ Denmark, Novo Nordisk Fdn Ctr Biosustainabil, Lyngby, Denmark
[2] Joint BioEnergy Inst, Emeryville, CA USA
[3] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Biol Syst & Engn Div, Berkeley, CA 94720 USA
[4] Univ Calif Berkeley, Dept Chem & Biomol Engn, Berkeley, CA 94720 USA
[5] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA
关键词
Genome editing; Metabolic engineering; CRISPR/Cas9; Recombineering; Yeast; Bacteria; DOUBLE-STRAND BREAKS; HETEROLOGOUS GENE-EXPRESSION; ESCHERICHIA-COLI GENOME; SPENT SULFITE LIQUOR; SACCHAROMYCES-CEREVISIAE; HOMOLOGOUS RECOMBINATION; HIGH-THROUGHPUT; IN-VIVO; CHROMOSOMAL INTEGRATION; PLASMID CONSTRUCTION;
D O I
10.1016/j.ymben.2015.12.003
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
One of the key drivers for successful metabolic engineering in microbes is the efficacy by which genomes can be edited. As such there are many methods to choose from when aiming to modify genomes, especially those of model organisms like yeast and bacteria. In recent years, clustered regularly interspaced palindromic repeats (CRISPR) and its associated proteins (Cas) have become the method of choice for precision genome engineering in many organisms due to their orthogonality, versatility and efficacy. Here we review the strategies adopted for implementation of RNA-guided CRISPR/Cas9 genome editing with special emphasis on their application for metabolic engineering of yeast and bacteria. Also, examples of how nuclease-deficient Cas9 has been applied for RNA-guided transcriptional regulation of target genes will be reviewed, as well as tools available for computer-aided design of guide-RNAs will be highlighted. Finally, this review will provide a perspective on the immediate challenges and opportunities foreseen by the use of CRISPR/Cas9 genome engineering and regulation in the context of metabolic engineering. (C) 2015 International Metabolic Engineering Society. Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:44 / 59
页数:16
相关论文
共 50 条
  • [21] Applications and advances of CRISPR/Cas9 in animal cancer model
    Xu, Min
    Weng, Qiaoyou
    Ji, Jiansong
    BRIEFINGS IN FUNCTIONAL GENOMICS, 2020, 19 (03) : 235 - 241
  • [22] Recent advances in spatiotemporal control of the CRISPR/Cas9 system
    Zhang, Junqi
    Zhou, Yuzi
    Qiao, Jie
    Liu, Yi
    COLLOIDS AND SURFACES B-BIOINTERFACES, 2025, 248
  • [23] CRISPR/Cas9-mediated genome engineering of CHO cell factories: Application and perspectives
    Lee, Jae Seong
    Grav, Lise Marie
    Lewis, Nathan E.
    Kildegaard, Helene Faustrup
    BIOTECHNOLOGY JOURNAL, 2015, 10 (07) : 979 - 994
  • [24] Optimization of Genome Engineering Approaches with the CRISPR/Cas9 System
    Li, Kai
    Wang, Gang
    Andersen, Troels
    Zhou, Pingzhu
    Pu, William T.
    PLOS ONE, 2014, 9 (08):
  • [25] CRISPR/Cas9 engineering of albino cystinuria Type A mice
    Beckermann, Thomas M.
    Welch, Richard C.
    Williams, Felisha M.
    Mortlock, Douglas P.
    Sha, Feng
    Ikizler, Talat A.
    Woodard, Lauren E.
    Wilson, Matthew H.
    GENESIS, 2020, 58 (05)
  • [26] CRISPR/Cas9 System: A Bacterial Tailor for Genomic Engineering
    Lone, Bilal Ahmad
    Karna, Shibendra Kumar Lal
    Ahmad, Faiz
    Shahi, Nerina
    Pokharel, Yuba Raj
    GENETICS RESEARCH INTERNATIONAL, 2018, 2018
  • [27] Engineering Plants for Geminivirus Resistance with CRISPR/Cas9 System
    Zaidi, Syed Shan-e-Ali
    Mansoor, Shahid
    Ali, Zahir
    Tashkandi, Manal
    Mahfouz, Magdy M.
    TRENDS IN PLANT SCIENCE, 2016, 21 (04) : 279 - 281
  • [28] CRISPR/Cas9 Immune System as a Tool for Genome Engineering
    Magdalena Hryhorowicz
    Daniel Lipiński
    Joanna Zeyland
    Ryszard Słomski
    Archivum Immunologiae et Therapiae Experimentalis, 2017, 65 : 233 - 240
  • [29] CRISPR/Cas9 Immune System as a Tool for Genome Engineering
    Hryhorowicz, Magdalena
    Lipianki, Daniel
    Zeyland, Joanna
    Slomski, Ryszard
    ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS, 2017, 65 (03) : 233 - 240
  • [30] CRISPR/Cas9 for Human Genome Engineering and Disease Research
    Xiong, Xin
    Chen, Meng
    Lim, Wendell A.
    Zhao, Dehua
    Qi, Lei S.
    ANNUAL REVIEW OF GENOMICS AND HUMAN GENETICS, VOL 17, 2016, 17 : 131 - 154